Description

Paclitaxel Concentrate for Infusions 6 mg/ml. 50 ml. (300 mg.) №1

Ingredients:

Each ml contains 6 mg of Paclitaxel. Other ingredients include ethanol, polyoxyethylated castor oil, and citric acid.

Dosage:

The recommended dosage is determined by a healthcare professional based on individual patient factors. It is typically administered intravenously over 3 hours.

Indications:

Paclitaxel is indicated for the treatment of various cancers including breast, ovarian, and lung cancer. It works by inhibiting the growth of cancer cells.

Contraindications:

Do not use Paclitaxel if you are allergic to it or have low white blood cell counts. It is important to discuss all potential risks with your healthcare provider.

Directions:

Follow all instructions provided by your healthcare provider for proper administration of Paclitaxel. It is important to receive this medication in a healthcare setting.

Scientific Evidence:

Studies have shown that Paclitaxel is effective in the treatment of various types of cancer. Research published in the Journal of Clinical Oncology demonstrated the efficacy of Paclitaxel in improving survival rates in patients with advanced ovarian cancer.

Additional Information:

Paclitaxel may cause side effects such as hair loss, nausea, and fatigue. It is important to report any adverse reactions to your healthcare provider promptly.

Paclitaxel exerts its pharmacological effects by disrupting the normal function of microtubules in cancer cells, leading to cell death. This mechanism makes it a valuable agent in the treatment of solid tumors.

Clinical trials have demonstrated the comparative effectiveness of Paclitaxel against other chemotherapy agents in terms of response rates and overall survival in certain cancer types. This positions Paclitaxel as a cornerstone in the management of various malignancies.